In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders
2007; Springer Science+Business Media; Volume: 193; Issue: 1 Linguagem: Inglês
10.1007/s00213-007-0758-3
ISSN1432-2072
AutoresLinda M. Rorick‐Kehn, Bryan G. Johnson, Karen M. Knitowski, Craig R. Salhoff, Jeffrey M. Witkin, Kenneth W. Perry, Kelly I. Griffey, Joseph P. Tizzano, James A. Monn, David L. McKinzie, Darryle D. Schoepp,
Tópico(s)Neurotransmitter Receptor Influence on Behavior
Referência(s)